Cargando…

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

INTRODUCTION: Growth hormone (GH) is an essential regulator of growth, body composition and fuel metabolism and, consequently, GH secretion is under the feedback control of numerous nutritional and endocrine mediators. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have been shown to exert ple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinla, Keiu, Vasar, Eero, Reppo, Ingrid, Sedman, Tuuli, Volke, Vallo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064408/ https://www.ncbi.nlm.nih.gov/pubmed/36800161 http://dx.doi.org/10.1007/s13300-023-01381-w

Ejemplares similares

Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1
por: Sedman, Tuuli, et al.
Publicado: (2016)

Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes
por: Reppo, Ingrid, et al.
Publicado: (2023)

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
por: Volke, Vallo, et al.
Publicado: (2022)

Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric Emptying
por: Marathe, Chinmay S., et al.
Publicado: (2022)

GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
por: Seppa, Kadri, et al.
Publicado: (2019)

The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonists
por: Urva, Shweta, et al.
Publicado: (2020)

Wfs1-deficient mice display altered function of serotonergic system and increased behavioral response to antidepressants
por: Visnapuu, Tanel, et al.
Publicado: (2013)

The GLP-1 agonist, exendin-4, stimulates LH secretion in female sheep
por: Simpson, Elizabeth M, et al.
Publicado: (2023)

Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study
por: Richards, Jesse, et al.
Publicado: (2023)

Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
por: Cignarelli, Angelo, et al.
Publicado: (2022)

Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome
por: Toots, Maarja, et al.
Publicado: (2018)

Hypothermia Alleviates Reductive Stress, a Root Cause of Ischemia Reperfusion Injury
por: Eskla, Kattri-Liis, et al.
Publicado: (2022)

Genetic Evidence for Repurposing of GLP1R (Glucagon‐Like Peptide‐1 Receptor) Agonists to Prevent Heart Failure
por: Daghlas, Iyas, et al.
Publicado: (2021)

Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study
por: Srinivasan, Dushyanth, et al.
Publicado: (2022)

Unilateral pitting edema of the leg as a manifestation of Graves’ disease: a case report
por: Volke, Vallo, et al.
Publicado: (2012)

Nitric Oxide Synthase Inhibitors as Antidepressants
por: Wegener, Gregers, et al.
Publicado: (2010)

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype
por: Jagomäe, Toomas, et al.
Publicado: (2021)

Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration
por: Plaas, Mario, et al.
Publicado: (2017)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Olfactory Receptor OR51E1 Mediates GLP-1 Secretion in Human and Rodent Enteroendocrine L Cells
por: Han, Ye Eon, et al.
Publicado: (2018)

Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1
por: Cui, Tengjiao, et al.
Publicado: (2018)

Glucolipotoxicity and GLP-1 secretion
por: Hong, Jung-Hee, et al.
Publicado: (2021)

AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion
por: Wang, Qiuyu, et al.
Publicado: (2018)

Growth in Children with HLA-Conferred Susceptibility to Type 1 Diabetes
por: Saare, Liisa, et al.
Publicado: (2022)

The Cardiovascular Effects of GLP-1 Receptor Agonists
por: Okerson, Theodore, et al.
Publicado: (2012)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Clinical Trial Highlights – GLP-1 agonists
por: McFarthing, Kevin, et al.
Publicado: (2020)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women
por: Muniyappa, Ranganath, et al.
Publicado: (2017)

Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study
por: Rawson, Timothy M, et al.
Publicado: (2021)

Evaluation of Spleen Stiffness in Young Healthy Volunteers Using Magnetic Resonance Elastography
por: Obrzut, Marzanna, et al.
Publicado: (2023)

Lsamp is implicated in the regulation of emotional and social behavior by use of alternative promoters in the brain
por: Philips, Mari-Anne, et al.
Publicado: (2014)

VHL-deficiency leads to reductive stress in renal cells
por: Vellama, Hans, et al.
Publicado: (2023)

Altered Pain Processing Associated with Administration of Dopamine Agonist and Antagonist in Healthy Volunteers
por: Martin, Sarah L., et al.
Publicado: (2022)

Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
por: Wang, Qinghua, et al.
Publicado: (2010)

A Case of New-Onset Vitiligo in a Healthy Volunteer After Administration of Adalimumab
por: Yang, Hee Joo, et al.
Publicado: (2021)

Male mice with deleted Wolframin (Wfs1) gene have reduced fertility
por: Noormets, Klari, et al.
Publicado: (2009)

Basal Insulin Use With GLP-1 Receptor Agonists
por: Anderson, Sarah L., et al.
Publicado: (2016)

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021)

Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans
por: Heni, Martin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ttjn3c9t0rrcgmned98v1qfk4i